Hippocratic AI vs Alan
Side-by-side on valuation, funding, investors, founders & more
Comparison updated: April 2026
Alan is valued at $5.8B — more than 3x Hippocratic AI's N/A.
Head-to-Head Verdict
Hippocratic AI
0 wins
Alan
4 wins
Key Numbers
🇺🇸 United States · Munjal Shah
Valuation
N/A
Total Funding
$120M
50-200 employees
🇫🇷 France · Jean-Charles Samuelian
Valuation
$5.8B
Total Funding
$750M
500-1000 employees
As AI Healthcare players, Hippocratic AI and Alan target overlapping customers despite operating from different countries. The stage gap — Hippocratic AI at Series B vs Alan at Series D — shapes how each company allocates capital and talent.
Analyst Summary
Built from real data · Updated April 2026
Companies
AI Healthcare remains a contested market, with Hippocratic AI and Alan among its most prominent entrants. Hippocratic AI develops a safety-focused AI platform designed to address the global shortage of healthcare professionals by deploying AI agents that perform patient-facing healthcare communication tasks including care navigation, medication adherence outreach, chronic disease monitoring, and post-discharge follow-up. Alan is an AI-powered health insurance platform that combines employer group health insurance products with a digital health companion application, using AI to personalise member health recommendations, streamline claims processing, and provide on-demand access to telehealth and mental health resources.
Funding & Valuation
Alan carries a disclosed valuation of $5.8B, while Hippocratic AI remains privately valued. With $750M raised, Alan has attracted substantially more capital than Hippocratic AI ($120M).
Growth Stage
Alan (est. 2016) predates Hippocratic AI (est. 2023) by 7 years, a significant head start in building market presence. Hippocratic AI is at Series B while Alan stands at Series D, indicating different levels of maturity and investor risk. Headcount tells a story too: Hippocratic AI has 50-200 employees and Alan has 500-1000.
Geography & Outlook
Based in 🇺🇸 United States and 🇫🇷 France respectively, Hippocratic AI and Alan tap into different talent markets and regulatory environments. A 18-point gap on the Awaira Score (Alan: 83, Hippocratic AI: 65) signals a clear difference in overall company strength. Hippocratic AI, led by Munjal Shah, and Alan, led by Jean-Charles Samuelian, each bring distinct leadership visions to the AI sector.
Funding Velocity
Hippocratic AI
Alan
Funding History
Hippocratic AI has completed 2 funding rounds, while Alan has gone through 1. Hippocratic AI's most recent round was a Series B of $50M, compared to Alan's Series E ($183M). Hippocratic AI is at Series B while Alan is at Series D — different points in their growth trajectory.
Team & Scale
Alan has the bigger team at roughly 500-1000 people — 10x the size of Hippocratic AI's 50-200. Alan has a 7-year head start, founded in 2016 vs Hippocratic AI's 2023. Geographically, they're in different markets — Hippocratic AI operates out of United States and Alan from France.
Metrics Comparison
| Metric | Hippocratic AI | Alan |
|---|---|---|
💰Valuation | N/A | $5.8B |
📈Total Funding | $120M | $750MWINS |
📅Founded | 2023WINS | 2016 |
🚀Stage | Series B | Series D |
👥Employees | 50-200 | 500-1000 |
🌍Country | United States | France |
🏷️Category | AI Healthcare | AI Healthcare |
⭐Awaira Score | 65 | 83WINS |
Key Differences
Funding gap: Alan has raised $630M more ($750M vs $120M)
Market experience: Alan has 7 years more (founded 2016 vs 2023)
Growth stage: Hippocratic AI is at Series B vs Alan at Series D
Team size: Hippocratic AI has 50-200 employees vs Alan's 500-1000
Market base: 🇺🇸 Hippocratic AI (United States) vs 🇫🇷 Alan (France)
Direct competitors: Both operate in the AI Healthcare market segment
Awaira Score: Alan scores 83/100 vs Hippocratic AI's 65/100
Which Should You Choose?
Use these signals to make the right call
Choose Hippocratic AI if…
- ✓United States-based for regional compliance or proximity
- ✓Hippocratic AI develops a safety-focused AI platform designed to address the global shortage of healthcare professionals by deploying AI agents that perform patient-facing healthcare communication tasks including care navigation, medication adherence outreach, chronic disease monitoring, and post-discharge follow-up
Choose Alan if…
Top Pick- ✓Higher Awaira Score — 83/100 vs 65/100
- ✓More established by valuation ($5.8B)
- ✓Stronger investor backing — raised $750M
- ✓More market experience — founded in 2016
- ✓France-based for regional compliance or proximity
- ✓Alan is an AI-powered health insurance platform that combines employer group health insurance products with a digital health companion application, using AI to personalise member health recommendations, streamline claims processing, and provide on-demand access to telehealth and mental health resources
Funding History
Hippocratic AI raised $120M across 2 rounds. Alan raised $750M across 1 round.
Hippocratic AI
Series B
Sep 2024
Lead: Andreessen Horowitz
Series A
Mar 2024
Lead: General Catalyst
Alan
Series E
Oct 2022
Lead: Coatue Management
Investor Comparison
No shared investors detected between these two companies.
Unique to Hippocratic AI
Unique to Alan
Users Also Compare
Explore Further
FAQ — Hippocratic AI vs Alan
Is Hippocratic AI bigger than Alan?▾
Which company raised more funding — Hippocratic AI or Alan?▾
Which company has a higher Awaira Score?▾
Who founded Hippocratic AI vs Alan?▾
What does Hippocratic AI do vs Alan?▾
Which company was founded first?▾
Which company has more employees?▾
Are Hippocratic AI and Alan competitors?▾
Bottom Line
Alan has a clear lead here — Awaira Score of 83 vs Hippocratic AI's 65. The difference comes down to funding depth and team scale.
Who Should You Watch?
Alan is in the stronger position — better score and deeper pockets. But Hippocratic AI has room to surprise, especially if they land a marquee investor. Follow both profiles on Awaira to track funding rounds, team changes, and score updates.